Robin Humphreys
- Molecular Biology top 5%
- Oncology top 5%
- Immunology top 5%
- Cancer Research top 5%
- Genetics top 10%
- Co-authors
- Jeffrey M. RosenLothar HennighausenJohn P. LydonBert W. O’MalleyVivian R. AlbertStanisław KrajewskiHans WeiherJohn C. Reed
- Topics
- Cell death mechanisms and regulation (29 papers)interferon and immune responses (8 papers)Cancer-related Molecular Pathways (6 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesGermanyIndia
In The Last Decade
Robin Humphreys
53 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 1.5k
- Oncology 903
- Immunology 461
- Cancer Research 367
- Genetics 320
Countries citing papers authored by Robin Humphreys
This map shows the geographic impact of Robin Humphreys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Humphreys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Humphreys more than expected).
Fields of papers citing papers by Robin Humphreys
This network shows the impact of papers produced by Robin Humphreys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Humphreys. The network helps show where Robin Humphreys may publish in the future.
Co-authorship network of co-authors of Robin Humphreys
This figure shows the co-authorship network connecting the top 25 collaborators of Robin Humphreys. A scholar is included among the top collaborators of Robin Humphreys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Humphreys. Robin Humphreys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 81 | |
| 2 | 28 | |
| 3 | 61 | |
| 4 | 54 | |
| 5 | 44 | |
| 6 | 50 | |
| 7 | 52 | |
| 8 | 31 | |
| 9 | 94 | |
| 10 | 50 | |
| 11 | HGS-TR2J, an agonistic, TRAIL receptor 2 monoclonal antibody, actively and rapidly stimulates the TRAIL receptor pathway that leads to significant inhibition of tumor growth in human tumor cell lines in vitro and in vivo | 2 |
| 12 | 129 | |
| 13 | Development of sensitive and specific immunohistochemical assays for pro-apoptotic TRAIL-receptors | 6 |
| 14 | Human agonistic anti-TRAIL receptor antibodies, HGS-ETR1 and HGS-ETR2, induce apoptosis in diverse hematological tumor lines | 5 |
| 15 | 66 | |
| 16 | 120 | |
| 17 | 72 | |
| 18 | 68 | |
| 19 | 17 | |
| 20 | 9 |
About Robin Humphreys
Robin Humphreys is a scholar working on Immunology, Cancer Research and Oncology, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (29 papers), interferon and immune responses (8 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Oncology (903 citations), Cancer Research (367 citations) and Immunology (461 citations). Robin Humphreys has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Jeffrey M. Rosen, Lothar Hennighausen, John P. Lydon, Bert W. O’Malley, Vivian R. Albert, Stanisław Krajewski, Hans Weiher, John C. Reed, Maryla Krajewska and Wendy Halpern. Their work appears in journals such as Journal of Biological Chemistry, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.